Local and circulating endothelial cells undergo endothelial to Mesenchymal Transition (EndMT) in response to musculoskeletal injury

Shailesh Agarwal, Shawn Loder, David Cholok, Joshua Peterson, John Li, David Fireman, Christopher Breuler, Hsiao Sung Hsieh, Kavitha Ranganathan, Charles Hwang, James Drake, Shuli Li, Charles K. Chan, Michael T. Longaker, Benjamin Levi

Research output: Contribution to journalArticle

Abstract

Endothelial-to-mesenchymal transition (EndMT) has been implicated in a variety of aberrant wound healing conditions. However, unambiguous evidence of EndMT has been elusive due to limitations of in vitro experimental designs and animal models. In vitro experiments cannot account for the myriad ligands and cells which regulate differentiation, and in vivo tissue injury models may induce lineage-independent endothelial marker expression in mesenchymal cells. By using an inducible Cre model to mark mesenchymal cells (Scx-creERT/tdTomato +) prior to injury, we demonstrate that musculoskeletal injury induces expression of CD31, VeCadherin, or Tie2 in mesenchymal cells. VeCadherin and Tie2 were expressed in non-endothelial cells (CD31-) present in marrow from uninjured adult mice, thereby limiting the specificity of these markers in inducible models (e.g. VeCadherin- or Tie2-creERT). However, cell transplantation assays confirmed that endothelial cells (Δ VeCadherin/CD31+/CD45-) isolated from uninjured hindlimb muscle tissue undergo in vivo EndMT when transplanted directly into the wound without intervening cell culture using PDGFRα, Osterix (OSX), SOX9, and Aggrecan (ACAN) as mesenchymal markers. These in vivo findings support EndMT in the presence of myriad ligands and cell types, using cell transplantation assays which can be applied for other pathologies implicated in EndMT including tissue fibrosis and atherosclerosis. Additionally, endothelial cell recruitment and trafficking are potential therapeutic targets to prevent EndMT.

Original languageEnglish (US)
Article number32514
JournalScientific reports
Volume6
DOIs
StatePublished - Sep 12 2016
Externally publishedYes

Fingerprint

Endothelial Cells
Wounds and Injuries
Cell Transplantation
Ligands
Aggrecans
Hindlimb
Wound Healing
Atherosclerosis
Fibrosis
Research Design
Animal Models
Cell Culture Techniques
Bone Marrow
Pathology
Muscles
In Vitro Techniques
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

Local and circulating endothelial cells undergo endothelial to Mesenchymal Transition (EndMT) in response to musculoskeletal injury. / Agarwal, Shailesh; Loder, Shawn; Cholok, David; Peterson, Joshua; Li, John; Fireman, David; Breuler, Christopher; Sung Hsieh, Hsiao; Ranganathan, Kavitha; Hwang, Charles; Drake, James; Li, Shuli; Chan, Charles K.; Longaker, Michael T.; Levi, Benjamin.

In: Scientific reports, Vol. 6, 32514, 12.09.2016.

Research output: Contribution to journalArticle

Agarwal, S, Loder, S, Cholok, D, Peterson, J, Li, J, Fireman, D, Breuler, C, Sung Hsieh, H, Ranganathan, K, Hwang, C, Drake, J, Li, S, Chan, CK, Longaker, MT & Levi, B 2016, 'Local and circulating endothelial cells undergo endothelial to Mesenchymal Transition (EndMT) in response to musculoskeletal injury', Scientific reports, vol. 6, 32514. https://doi.org/10.1038/srep32514
Agarwal, Shailesh ; Loder, Shawn ; Cholok, David ; Peterson, Joshua ; Li, John ; Fireman, David ; Breuler, Christopher ; Sung Hsieh, Hsiao ; Ranganathan, Kavitha ; Hwang, Charles ; Drake, James ; Li, Shuli ; Chan, Charles K. ; Longaker, Michael T. ; Levi, Benjamin. / Local and circulating endothelial cells undergo endothelial to Mesenchymal Transition (EndMT) in response to musculoskeletal injury. In: Scientific reports. 2016 ; Vol. 6.
@article{2f20c1b8999b4423b9e49f7d35509e54,
title = "Local and circulating endothelial cells undergo endothelial to Mesenchymal Transition (EndMT) in response to musculoskeletal injury",
abstract = "Endothelial-to-mesenchymal transition (EndMT) has been implicated in a variety of aberrant wound healing conditions. However, unambiguous evidence of EndMT has been elusive due to limitations of in vitro experimental designs and animal models. In vitro experiments cannot account for the myriad ligands and cells which regulate differentiation, and in vivo tissue injury models may induce lineage-independent endothelial marker expression in mesenchymal cells. By using an inducible Cre model to mark mesenchymal cells (Scx-creERT/tdTomato +) prior to injury, we demonstrate that musculoskeletal injury induces expression of CD31, VeCadherin, or Tie2 in mesenchymal cells. VeCadherin and Tie2 were expressed in non-endothelial cells (CD31-) present in marrow from uninjured adult mice, thereby limiting the specificity of these markers in inducible models (e.g. VeCadherin- or Tie2-creERT). However, cell transplantation assays confirmed that endothelial cells (Δ VeCadherin/CD31+/CD45-) isolated from uninjured hindlimb muscle tissue undergo in vivo EndMT when transplanted directly into the wound without intervening cell culture using PDGFRα, Osterix (OSX), SOX9, and Aggrecan (ACAN) as mesenchymal markers. These in vivo findings support EndMT in the presence of myriad ligands and cell types, using cell transplantation assays which can be applied for other pathologies implicated in EndMT including tissue fibrosis and atherosclerosis. Additionally, endothelial cell recruitment and trafficking are potential therapeutic targets to prevent EndMT.",
author = "Shailesh Agarwal and Shawn Loder and David Cholok and Joshua Peterson and John Li and David Fireman and Christopher Breuler and {Sung Hsieh}, Hsiao and Kavitha Ranganathan and Charles Hwang and James Drake and Shuli Li and Chan, {Charles K.} and Longaker, {Michael T.} and Benjamin Levi",
year = "2016",
month = "9",
day = "12",
doi = "10.1038/srep32514",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Local and circulating endothelial cells undergo endothelial to Mesenchymal Transition (EndMT) in response to musculoskeletal injury

AU - Agarwal, Shailesh

AU - Loder, Shawn

AU - Cholok, David

AU - Peterson, Joshua

AU - Li, John

AU - Fireman, David

AU - Breuler, Christopher

AU - Sung Hsieh, Hsiao

AU - Ranganathan, Kavitha

AU - Hwang, Charles

AU - Drake, James

AU - Li, Shuli

AU - Chan, Charles K.

AU - Longaker, Michael T.

AU - Levi, Benjamin

PY - 2016/9/12

Y1 - 2016/9/12

N2 - Endothelial-to-mesenchymal transition (EndMT) has been implicated in a variety of aberrant wound healing conditions. However, unambiguous evidence of EndMT has been elusive due to limitations of in vitro experimental designs and animal models. In vitro experiments cannot account for the myriad ligands and cells which regulate differentiation, and in vivo tissue injury models may induce lineage-independent endothelial marker expression in mesenchymal cells. By using an inducible Cre model to mark mesenchymal cells (Scx-creERT/tdTomato +) prior to injury, we demonstrate that musculoskeletal injury induces expression of CD31, VeCadherin, or Tie2 in mesenchymal cells. VeCadherin and Tie2 were expressed in non-endothelial cells (CD31-) present in marrow from uninjured adult mice, thereby limiting the specificity of these markers in inducible models (e.g. VeCadherin- or Tie2-creERT). However, cell transplantation assays confirmed that endothelial cells (Δ VeCadherin/CD31+/CD45-) isolated from uninjured hindlimb muscle tissue undergo in vivo EndMT when transplanted directly into the wound without intervening cell culture using PDGFRα, Osterix (OSX), SOX9, and Aggrecan (ACAN) as mesenchymal markers. These in vivo findings support EndMT in the presence of myriad ligands and cell types, using cell transplantation assays which can be applied for other pathologies implicated in EndMT including tissue fibrosis and atherosclerosis. Additionally, endothelial cell recruitment and trafficking are potential therapeutic targets to prevent EndMT.

AB - Endothelial-to-mesenchymal transition (EndMT) has been implicated in a variety of aberrant wound healing conditions. However, unambiguous evidence of EndMT has been elusive due to limitations of in vitro experimental designs and animal models. In vitro experiments cannot account for the myriad ligands and cells which regulate differentiation, and in vivo tissue injury models may induce lineage-independent endothelial marker expression in mesenchymal cells. By using an inducible Cre model to mark mesenchymal cells (Scx-creERT/tdTomato +) prior to injury, we demonstrate that musculoskeletal injury induces expression of CD31, VeCadherin, or Tie2 in mesenchymal cells. VeCadherin and Tie2 were expressed in non-endothelial cells (CD31-) present in marrow from uninjured adult mice, thereby limiting the specificity of these markers in inducible models (e.g. VeCadherin- or Tie2-creERT). However, cell transplantation assays confirmed that endothelial cells (Δ VeCadherin/CD31+/CD45-) isolated from uninjured hindlimb muscle tissue undergo in vivo EndMT when transplanted directly into the wound without intervening cell culture using PDGFRα, Osterix (OSX), SOX9, and Aggrecan (ACAN) as mesenchymal markers. These in vivo findings support EndMT in the presence of myriad ligands and cell types, using cell transplantation assays which can be applied for other pathologies implicated in EndMT including tissue fibrosis and atherosclerosis. Additionally, endothelial cell recruitment and trafficking are potential therapeutic targets to prevent EndMT.

UR - http://www.scopus.com/inward/record.url?scp=84987816222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987816222&partnerID=8YFLogxK

U2 - 10.1038/srep32514

DO - 10.1038/srep32514

M3 - Article

C2 - 27616463

AN - SCOPUS:84987816222

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 32514

ER -